Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and 5-fluorodopamine

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with 5-fluorodopamine in 1 studies

Compound Research Comparison

Studies
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)
Trials
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)
Recent Studies (post-2010)
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)
Studies
(5-fluorodopamine)
Trials
(5-fluorodopamine)
Recent Studies (post-2010) (5-fluorodopamine)
330403376816

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brücke, T; Chiueh, CC; Cohen, RM; Kung, HF; McLellan, CA; Singhaniyom, W; Tsai, YF1

Other Studies

1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and 5-fluorodopamine

ArticleYear
Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.
    Brain research, 1988, Jun-21, Volume: 453, Issue:1-2

    Topics: Animals; Autoradiography; Benzamides; Binding, Competitive; Caudate Nucleus; Dopamine; Ergolines; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Olfactory Bulb; Pyrrolidines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Septal Nuclei

1988